Sign in
CompletedNo phase

Slowing Axial Elongation in Pediatric Myopia Using C.A.R.E. Technology

Key facts

Who runs it
Benha University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
15 Jan 2024
Ended
15 Mar 2025
Type of study
Interventional
Treatments tested
  • Cylindrical Annular Refractive Element (C.A.R.E.) Spectacle Lenses
Record updated
12 March 2026

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Children aged 6-12 years at enrollment
  • Spherical equivalent refractive error between -0.75 and -6.00 diopters
  • Astigmatism ≤1.50 diopters
  • Best-corrected visual acuity of 0.1 logMAR or better
  • Ability to comply with full-time spectacle wear
  • Informed consent obtained from parent or legal guardian

Who cannot take part

  • Previous myopia control treatment (e.g., atropine therapy, orthokeratology)
  • History of ocular surgery
  • Systemic disease affecting vision
  • Amblyopia or strabismus
  • Keratoconus or other corneal pathology
  • Poor compliance with spectacle wear

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective interventional study evaluates the effectiveness of Cylindrical Annular Refractive Element (C.A.R.E.) spectacle lenses in slowing axial elongation and myopia progression in children aged 6-12 years. A total of 100 participants with myopia ranging from -0.75 to -6.00 diopters were enrolled and prescribed C.A.R.E. spectacle lenses for full-time wear over a 12-month period. Clinical examinations are conducted at baseline, 6 months, and 12 months and include measurements of axial length, cycloplegic refraction, and visual acuity.

Read full original descriptionShow less

The primary outcome measure is the change in axial length over the 12-month study period. Secondary outcomes include changes in spherical equivalent refractive error, visual acuity, and safety outcomes related to spectacle lens wear.

The group in the trial

  • C.A.R.E. Spectacle Lenses - Pediatric Myopia ControlTreatment being tested

    All participants received Cylindrical Annular Refractive Element (C.A.R.E.) spectacle lenses. The lenses feature a central optical zone for distance correction surrounded by concentric annular cylindrical elements designed to modify peripheral retinal defocus and slow axial elongation. Participants were instructed to wear the spectacles full-time during waking hours for 12 months. Follow-up examinations occurred at baseline, 6 months, and 12 months to assess axial length, refractive error, visual acuity, and safety.

    Treatment: Cylindrical Annular Refractive Element (C.A.R.E.) Spectacle Lenses

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Slowing Axial Elongation in Pediatric Myopia: One-Year Clinical Outcomes of Cylindrical Annular Refractive Elements (C.A.R.E.) Technology
Record updated
12 March 2026